Your browser doesn't support javascript.
loading
Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies.
Fox, Thomas A; Kirkwood, Amy A; Enfield, Louise; O'Reilly, Maeve; Arulogun, Suzanne; D'Sa, Shirley; O'Nions, Jenny; Kavi, Janki; Vitsaras, Evan; Townsend, William; Burns, Siobhan O; Gohil, Satyen H; Cwynarski, Kate; Thomson, Kirsty J; Noursadeghi, Mahdad; Heyderman, Robert S; Rampling, Tommy; Ardeshna, Kirit M; McCoy, Laura E; Morris, Emma C.
Afiliación
  • Fox TA; UCL Institute of Immunity and Transplantation, University College London, London, UK.
  • Kirkwood AA; Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Enfield L; CR UK and UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, UK.
  • O'Reilly M; Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Arulogun S; Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • D'Sa S; Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • O'Nions J; Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Kavi J; Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Vitsaras E; Immunology, Royal Free London Hospitals NHS Foundation Trust, London, UK.
  • Townsend W; Health Services Laboratories, London, UK.
  • Burns SO; Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Gohil SH; UCL Institute of Immunity and Transplantation, University College London, London, UK.
  • Cwynarski K; Immunology, Royal Free London Hospitals NHS Foundation Trust, London, UK.
  • Thomson KJ; Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Noursadeghi M; Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Heyderman RS; Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Rampling T; Research Department of Infection, University College London, London, UK.
  • Ardeshna KM; Department of Infectious Disease, University College London Hospitals NHS Foundation Trust, London, UK.
  • McCoy LE; Research Department of Infection, University College London, London, UK.
  • Morris EC; Department of Infectious Disease, University College London Hospitals NHS Foundation Trust, London, UK.
Br J Haematol ; 195(5): 706-709, 2021 12.
Article en En | MEDLINE | ID: mdl-34545952

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Subgrupos Linfocitarios / Vacunación / COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Br J Haematol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Subgrupos Linfocitarios / Vacunación / COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Br J Haematol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido